Login / Signup

Methodology of the BIOPACT RCT, a Multi-center, Randomized, Non-inferiority Trial Evaluating Safety and Efficacy of Passeo-18 Lux Drug-Coated Balloon (DCB) of Biotronik Compared to the Medtronic IN.PACT Admiral DCB in the Treatment of Subjects with Lesions of the Femoropopliteal Artery.

Koen DelooseWouter LansinkMarianne BrodmannMartin WernerKoen KeirseYann GouëfficJürgen VerbistLieven MaeneJeroen HendriksJerome BrunetEric DucasseKara LeventAntoine SauguetSébastien DégliseFemke Vandael
Published in: Cardiovascular and interventional radiology (2022)
As full enrolment was reached by the beginning of September, the investigators expect complete analysis of the primary endpoints by the end of 2022; Meanwhile preliminary results will be disclosed during 2022. As in terms of randomized head-to-head efficacy and safety analysis, this study on paclitaxel coated balloons may provide additional information to clinicians and healthcare providers. Trial registration ClinicalTrials.gov ID: NCT03884257 LEVEL OF EVIDENCE: Level 2, Randomized trial.
Keyphrases